Media & Events
Follow us here for the latest updates on our platform technology development, assets and corporate events.
PRESS RELEASES & NEWS
January 21, 2025
Cell BioEngines Announces Establishment of New R&D Facility to Further Advance Its Platform and Pipeline of Innovative Cell Therapies
September 24, 2024
Cell BioEngines, Inc: Oncology Startup Chosen For SCbioDrive Accelerator Program
July 20, 2024
Cell BioEngines Secures an Additional $2 Million in Funding From SOSV and the Empire State Development’s New York Ventures
February 08, 2024
Cell BioEngines to Present at the 2024 BIO CEO & Investor Conference
JANUARY 13, 2024
SOSV-backed Biotech Firm Cell BioEngines Decides New York Is the Place to Be
December 29, 2023
Cell BioEngines Enters Agreement with Miltenyi Bioindustry to Manufacture Hematopoietic Cell Therapy Clinical Program.
September 13, 2023
Cell BioEngines Founder and CEO Dr. Ajay Vishwakarma Interview at IndieBio NY Class 6 Online Demo Day.
September 07, 2023
Cell BioEngines Licenses Patent for Allogeneic Hematopoietic Cell Transplantation in Oncology.
JANUARY 25, 2023
Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer.